{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:19:04Z","timestamp":1784557144527,"version":"3.55.0"},"reference-count":97,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>\n                    Over the last years, the knowledge of MEN2 and non-MEN2 familial forms of pheochromocytoma (PHEO) has increased. In MEN2, PHEO is the second most frequent disease: the penetrance and age at diagnosis depend on the mutation of\n                    <jats:italic>RET<\/jats:italic>\n                    . Given the prevalence of bilateral PHEO (50% by age 50), adrenal sparing surgery, aimed at sparing a part of the adrenal cortex to avoid adrenal insufficiency, should be systematically considered in patients with bilateral PHEO. Non-MEN2 familial forms of PHEO now include more than 20 genes: however, only small phenotypic series have been reported, suggesting that phenotypic features of isolated hereditary PHEO must be better explored, and follow-up series are needed to better understand the outcome of patients carrying mutations of these genes. The first part of this review will mainly focus on these points. In the second part, a focus will be given on MEN2 and non-MEN2 familial forms of hyperparathyroidism (HPTH). Again, the management of MEN2 HPTH should be aimed at curing the disease while preserving an optimal quality of life by a tailored parathyroidectomy. The phenotypes and outcome of MEN1-, MEN4- and HRPT2-related HPTH are briefly described, with a focus on the most recent literature data and is compared with familial hypocalciuric hypercalcemia.\n                  <\/jats:p>","DOI":"10.1530\/erc-17-0266","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T20:25:34Z","timestamp":1504643134000},"page":"T15-T28","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":23,"title":["Looking beyond the thyroid: advances in the understanding of pheochromocytoma and hyperparathyroidism phenotypes in MEN2 and of non-MEN2 familial forms"],"prefix":"10.1530","volume":"25","author":[{"given":"Carole","family":"Guerin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Romanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2018011817200991000_25.2.T15.1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-3360"},{"key":"2018011817200991000_25.2.T15.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2083"},{"key":"2018011817200991000_25.2.T15.3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.beem.2010.01.002","article-title":"VHL disease","volume":"24","author":"Barontini","year":"2010","journal-title":"Best Practice and Research: Clinical Endocrinology and Metabolism"},{"key":"2018011817200991000_25.2.T15.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0780"},{"key":"2018011817200991000_25.2.T15.5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncology"},{"key":"2018011817200991000_25.2.T15.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-003-2690-4"},{"key":"2018011817200991000_25.2.T15.7","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0013"},{"key":"2018011817200991000_25.2.T15.8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2789"},{"key":"2018011817200991000_25.2.T15.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0160"},{"key":"2018011817200991000_25.2.T15.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01428.x"},{"key":"2018011817200991000_25.2.T15.11","doi-asserted-by":"publisher","DOI":"10.1038\/ng1048"},{"key":"2018011817200991000_25.2.T15.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3891"},{"key":"2018011817200991000_25.2.T15.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70154-8"},{"key":"2018011817200991000_25.2.T15.14","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-15-0175"},{"key":"2018011817200991000_25.2.T15.15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0549"},{"key":"2018011817200991000_25.2.T15.16","unstructured":"Castinetti F Maia AL Peczkowska M Barontini M Hasse-Lazar K Links TP Toledo RA Dvorakova S Mian C Bugalho MJ , et al . 2017 The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations. Endocrine-Related Cancer 24 L63\u2013L67. (https:\/\/doi.org\/10.1530\/ERC-17-0189)"},{"key":"2018011817200991000_25.2.T15.17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","article-title":"Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature","volume":"31","author":"Christakis","year":"2016","journal-title":"International Journal of Surgery"},{"key":"2018011817200991000_25.2.T15.18","doi-asserted-by":"publisher","DOI":"10.1038\/ng.861"},{"key":"2018011817200991000_25.2.T15.19","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00109-015-1306-y","article-title":"Functional and in silico assessment of MAX variants of unknown significance","volume":"93","author":"Comino-Mendez","year":"2015","journal-title":"Journal of Molecular Medicine"},{"key":"2018011817200991000_25.2.T15.20","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103218"},{"key":"2018011817200991000_25.2.T15.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3648"},{"key":"2018011817200991000_25.2.T15.22","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.00838"},{"key":"2018011817200991000_25.2.T15.23","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.153320"},{"key":"2018011817200991000_25.2.T15.24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2046"},{"key":"2018011817200991000_25.2.T15.25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/imj.12088","article-title":"Novel mutation in the TMEM127 gene associated with phaeochromocytoma","volume":"43","author":"Elston","year":"2013","journal-title":"Internal Medicine Journal"},{"key":"2018011817200991000_25.2.T15.26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"2018011817200991000_25.2.T15.27","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21385"},{"key":"2018011817200991000_25.2.T15.28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1301302"},{"key":"2018011817200991000_25.2.T15.29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"key":"2018011817200991000_25.2.T15.30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3659"},{"key":"2018011817200991000_25.2.T15.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.10.012"},{"key":"2018011817200991000_25.2.T15.32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/cen.13163","article-title":"Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1","volume":"86","author":"Gruber","year":"2017","journal-title":"Clinical Endocrinology"},{"key":"2018011817200991000_25.2.T15.33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"American Journal of Human Genetics"},{"key":"2018011817200991000_25.2.T15.34","doi-asserted-by":"crossref","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"key":"2018011817200991000_25.2.T15.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03648.x"},{"key":"2018011817200991000_25.2.T15.36","first-page":"966","article-title":"Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A.","volume-title":"Surgery","volume":"120","author":"Herfarth","year":"1996"},{"key":"2018011817200991000_25.2.T15.37","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-015-1755-2"},{"key":"2018011817200991000_25.2.T15.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1131-z"},{"key":"2018011817200991000_25.2.T15.39","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.156018"},{"key":"2018011817200991000_25.2.T15.40","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-015-1342-7"},{"key":"2018011817200991000_25.2.T15.41","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-1106"},{"key":"2018011817200991000_25.2.T15.42","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-0052"},{"key":"2018011817200991000_25.2.T15.43","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt201"},{"issue":"Supplement 2","key":"2018011817200991000_25.2.T15.44","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.33549\/physiolres.932789","article-title":"HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors","volume":"63","author":"Jochmanova","year":"2014","journal-title":"Physiological Research"},{"key":"2018011817200991000_25.2.T15.45","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1390410"},{"key":"2018011817200991000_25.2.T15.46","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0233"},{"key":"2018011817200991000_25.2.T15.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2014.09.002"},{"key":"2018011817200991000_25.2.T15.48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2015-2592","article-title":"Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2018011817200991000_25.2.T15.49","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900123"},{"key":"2018011817200991000_25.2.T15.50","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000658-199306000-00001","article-title":"Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes","volume":"217","author":"Lairmore","year":"1993","journal-title":"Annals of Surgery"},{"key":"2018011817200991000_25.2.T15.51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4491"},{"key":"2018011817200991000_25.2.T15.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(96)80056-0"},{"key":"2018011817200991000_25.2.T15.53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498"},{"key":"2018011817200991000_25.2.T15.54","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0130"},{"key":"2018011817200991000_25.2.T15.55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3192"},{"key":"2018011817200991000_25.2.T15.56","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0336"},{"key":"2018011817200991000_25.2.T15.57","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e32835f45c5"},{"key":"2018011817200991000_25.2.T15.58","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-009-9250-z"},{"key":"2018011817200991000_25.2.T15.59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.t01-1-01755.x"},{"key":"2018011817200991000_25.2.T15.60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/SLA.0000000000001464","article-title":"Management of the parathyroid glands during preventive thyroidectomy in patients with multiple endocrine neoplasia type 2","volume":"262","author":"Moley","year":"2015","journal-title":"Annals of Surgery"},{"key":"2018011817200991000_25.2.T15.61","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/cen.13265","article-title":"Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1","volume":"86","author":"Moramarco","year":"2017","journal-title":"Clinical Endocrinology"},{"key":"2018011817200991000_25.2.T15.62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0114"},{"key":"2018011817200991000_25.2.T15.63","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1440037"},{"key":"2018011817200991000_25.2.T15.64","doi-asserted-by":"crossref","first-page":"42074","DOI":"10.1038\/srep42074","article-title":"Differences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations","volume":"7","author":"Oczko-Wojciechowska","year":"2017","journal-title":"Scientific Reports"},{"key":"2018011817200991000_25.2.T15.65","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12253-016-0050-0","article-title":"Novel SDHB and TMEM127 mutations in patients with pheochromocytoma\/paraganglioma syndrome","volume":"22","author":"Patocs","year":"2016","journal-title":"Pathology and Oncology Research"},{"key":"2018011817200991000_25.2.T15.66","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12218"},{"key":"2018011817200991000_25.2.T15.67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603877103"},{"key":"2018011817200991000_25.2.T15.68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsurg.2008.02.003","article-title":"Efficacy of 4D-CT preoperative localization in 2 patients with MEN 2A","volume":"65","author":"Philip","year":"2008","journal-title":"Journal of Surgical Education"},{"key":"2018011817200991000_25.2.T15.69","doi-asserted-by":"publisher","DOI":"10.1038\/ng.533"},{"key":"2018011817200991000_25.2.T15.70","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1319"},{"key":"2018011817200991000_25.2.T15.71","first-page":"23","article-title":"Genotype-phenotype relationship in multiple endocrine neoplasia type 2","volume":"8","author":"Raue","year":"2009","journal-title":"Implications for Clinical Management: Hormones"},{"key":"2018011817200991000_25.2.T15.72","first-page":"302","article-title":"Pathological and genetic characterization of bilateral adrenomedullary hyperplasia in a patient with germline MAX mutation.","volume-title":"Endocrine Pathology","volume":"28","author":"Romanet","year":"2017"},{"key":"2018011817200991000_25.2.T15.73","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23378"},{"key":"2018011817200991000_25.2.T15.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.12.012"},{"key":"2018011817200991000_25.2.T15.75","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4158\/EP10050.OR","article-title":"Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A","volume":"17","author":"Scholten","year":"2011","journal-title":"Endocrine Practice"},{"key":"2018011817200991000_25.2.T15.76","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0148"},{"key":"2018011817200991000_25.2.T15.77","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.487"},{"key":"2018011817200991000_25.2.T15.78","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cpet.2015.03.005","article-title":"PET\/computed tomography in neuroendocrine tumor: value to patient management and survival outcomes","volume":"10","author":"Shamim","year":"2015","journal-title":"PET Clinics"},{"key":"2018011817200991000_25.2.T15.79","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031237"},{"key":"2018011817200991000_25.2.T15.80","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4158\/EP13417.OR","article-title":"Pheochromocytoma in neurofibromatosis type 1: when should it be suspected?","volume":"20","author":"Shinall","year":"2014","journal-title":"Endocrine Practice"},{"key":"2018011817200991000_25.2.T15.81","unstructured":"Singh Ospina N Sebo TJ Thompson GB Clarke BL Young WF Jr 2014 Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 \u2013 case report and review of the literature. Clinical Endocrinology [epub]. (https:\/\/doi.org\/10.1111\/cen.12714)"},{"key":"2018011817200991000_25.2.T15.82","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0084"},{"key":"2018011817200991000_25.2.T15.83","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2215-8"},{"key":"2018011817200991000_25.2.T15.84","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2265.2012.04421.x","article-title":"Identical germline mutations in the TMEM127 gene in two unrelated Japanese patients with bilateral pheochromocytoma","volume":"77","author":"Takeichi","year":"2012","journal-title":"Clinical Endocrinology"},{"key":"2018011817200991000_25.2.T15.85","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"Journal of Internal Medicine"},{"key":"2018011817200991000_25.2.T15.86","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1230"},{"key":"2018011817200991000_25.2.T15.87","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1653"},{"key":"2018011817200991000_25.2.T15.88","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1248"},{"key":"2018011817200991000_25.2.T15.89","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2473"},{"key":"2018011817200991000_25.2.T15.90","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0818"},{"key":"2018011817200991000_25.2.T15.91","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3442"},{"key":"2018011817200991000_25.2.T15.92","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e32835fcc45"},{"key":"2018011817200991000_25.2.T15.93","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4375"},{"key":"2018011817200991000_25.2.T15.94","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1204"},{"key":"2018011817200991000_25.2.T15.95","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0335"},{"key":"2018011817200991000_25.2.T15.96","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1830"},{"key":"2018011817200991000_25.2.T15.97","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K09E-005"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/25\/2\/ERC-17-0266.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/ERC-17-0266","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:54:23Z","timestamp":1784555663000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/25\/2\/T15-T28\/25210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":97,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/erc-17-0266","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}